Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700027407

Trial Profile

Clinical Trials Insight: 700027407

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2008

At a glance

  • Drugs Plovamer (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 18 Sep 2008 Further data was presented at the World Congress on Treatment and Research in Multiple Sclerosis.
    • 09 Jun 2008 Results presented at the 17th European Neurological Society and the Federation of Clinical Immunology Societies in June 2008.
    • 18 Mar 2008 Status changed from in progress to completed according to a Peptimmune media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top